Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance.
- NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_assertion description "[Currently, the most efficacious treatment for malignant gliomas is temozolomide; however, gliomas expressing the DNA repair enzyme O(6)-methylguanine-DNA methyltransferase (MGMT) are resistant to this drug.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance.
- NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_assertion evidence source_evidence_literature NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance.
- NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_assertion SIO_000772 18089777 NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance.
- NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_assertion wasDerivedFrom befree-2016 NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance.
- NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_assertion wasGeneratedBy ECO_0000203 NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance.
- befree-2016 importedOn "2016-02-19" NP645916.RAkH39l6PcNNDWH_DQAufdSS-To_AJtVZ6Q_fgWjMAZ3E130_provenance.